Key result
Left atrial appendage occlusion serves as an effective alternative for stroke prevention in patients with nonvalvular atrial fibrillation who are unsuitable for long-term oral anticoagulation.
Why the study?
Selecting appropriate candidates for LAAO requires a comprehensive evaluation of clinical factors, which presents a challenge in clinical practice.
This review provides an overview of current recommendations and key clinical factors for selecting appropriate candidates for left atrial appendage occlusion in patients with nonvalvular atrial fibrillation.
Atrial fibrillation (AF) is one the most prevalent arrhythmias globally and is associated with a significantly higher risk of morbidity and mortality, including an up to five-fold increase in risk of stroke. While oral anticoagulation therapy remains the standard approach for stroke prevention in nonvalvular AF, left atrial appendage occlusion (LAAO) has emerged as a viable alternative for patients who are intolerant to long-term oral anticoagulation therapy. However, selecting appropriate candidates for LAAO requires a comprehensive evaluation that considers various clinical factors, although this presents a challenge in clinical practice. This review aims to provide an overview of the current recommendations for patient selection in LAAO procedures and the key factors that need to be considered both before and after the procedure, as well as the ongoing advancements in this field that may facilitate the selection of patients for LAAO.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2023) conducted a review in Atrial fibrillation. Left atrial appendage occlusion (LAAO) vs. Oral anticoagulation (OAC) was evaluated. Left atrial appendage occlusion serves as an effective alternative for stroke prevention in patients with nonvalvular atrial fibrillation who are unsuitable for long-term oral anticoagulation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: